Page last updated: 2024-09-04

1,3-dicapryloylglycerol and tipranavir

1,3-dicapryloylglycerol has been researched along with tipranavir in 1 studies

Compound Research Comparison

Studies
(1,3-dicapryloylglycerol)
Trials
(1,3-dicapryloylglycerol)
Recent Studies (post-2010)
(1,3-dicapryloylglycerol)
Studies
(tipranavir)
Trials
(tipranavir)
Recent Studies (post-2010) (tipranavir)
8002894247

Protein Interaction Comparison

ProteinTaxonomy1,3-dicapryloylglycerol (IC50)tipranavir (IC50)
Protease Human immunodeficiency virus 10.03
CAAX prenyl protease 1 homologMus musculus (house mouse)1.2

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, S; Darrington, RT; Dudhedia, MS; Jones, PJ; Krill, SL; Smoliga, JA; Tamblyn, T; Wang, Z1

Other Studies

1 other study(ies) available for 1,3-dicapryloylglycerol and tipranavir

ArticleYear
Drug-excipient complexation in lipid based delivery systems: an investigation of the Tipranavir-1,3-dioctanolyglycerol complex.
    Journal of pharmaceutical sciences, 2009, Volume: 98, Issue:5

    Topics: Algorithms; Anti-HIV Agents; Calorimetry, Differential Scanning; Chromatography, High Pressure Liquid; Diglycerides; Drug Delivery Systems; Lipids; Magnetic Resonance Spectroscopy; Nonlinear Dynamics; Pyridines; Pyrones; Solubility; Solvents; Sulfonamides; Surface-Active Agents; X-Ray Diffraction

2009